Flagship unveils gut-focused upstart Kintai, with former GSK exec as chief
Prolific venture group Flagship Pioneering has spawned a fresh biopharma player with a former big pharma exec at the helm: Kintai Therapeutics. The Cambridge …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
